| Code | 4887E | ||||||||||
| MA number | 56/0253/23-S | ||||||||||
| Product Form: | tbl slg 30x240 µg (fľ.HDPE) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 56 - HORMONA (LIEČIVA S HORMONÁLNOU AKTIVITOU) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 30 | ||||||||||
| Route of admin.: | Sublingual use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 15.11.2023 |
| Validity: | 15.11.2028 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric contraindication: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Dezmopresín Stada_tbl slg_10_2023.pdf
|
| SPC: |
SPC_Dezmopresín Stada_tbl slg_10_2023.pdf
|
| Safety feature | Yes |
| Data update: | 15.11.2023 |
